NO20055015L - T-type calcium kanalblokkere - Google Patents
T-type calcium kanalblokkereInfo
- Publication number
- NO20055015L NO20055015L NO20055015A NO20055015A NO20055015L NO 20055015 L NO20055015 L NO 20055015L NO 20055015 A NO20055015 A NO 20055015A NO 20055015 A NO20055015 A NO 20055015A NO 20055015 L NO20055015 L NO 20055015L
- Authority
- NO
- Norway
- Prior art keywords
- calcium channel
- type calcium
- nr16r17
- cr7r8
- cr5r6
- Prior art date
Links
- 102000003691 T-Type Calcium Channels Human genes 0.000 title abstract 2
- 108090000030 T-Type Calcium Channels Proteins 0.000 title abstract 2
- 229940127291 Calcium channel antagonist Drugs 0.000 title 1
- 239000000480 calcium channel blocker Substances 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 abstract 1
- -1 1,4-dihydropyridine compound Chemical class 0.000 abstract 1
- 101150020251 NR13 gene Proteins 0.000 abstract 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
- C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003090916 | 2003-03-28 | ||
| JP2003393893 | 2003-11-25 | ||
| PCT/JP2004/004432 WO2004087172A1 (ja) | 2003-03-28 | 2004-03-29 | Ｔ型カルシウムチャネル阻害剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20055015D0 NO20055015D0 (no) | 2005-10-27 |
| NO20055015L true NO20055015L (no) | 2005-11-15 |
Family
ID=33134293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055015A NO20055015L (no) | 2003-03-28 | 2005-10-27 | T-type calcium kanalblokkere |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7563782B2 (de) |
| EP (1) | EP1609504A4 (de) |
| JP (1) | JP4539862B2 (de) |
| KR (1) | KR100870527B1 (de) |
| AU (1) | AU2004226547B2 (de) |
| CA (1) | CA2520628C (de) |
| NO (1) | NO20055015L (de) |
| NZ (1) | NZ542681A (de) |
| RU (1) | RU2326886C2 (de) |
| TW (1) | TW200503733A (de) |
| WO (1) | WO2004087172A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100749843B1 (ko) * | 2006-07-13 | 2007-08-21 | 한국과학기술연구원 | Ｔ-타입 칼슘 채널에 억제 활성을 지닌 신규2,4-디옥소-퀴나졸린 유도체 및 이의 제조방법 |
| JP2010526073A (ja) * | 2007-05-02 | 2010-07-29 | ティーエーユー・セラピューティクス・エルエルシー | 癌または前癌性症状およびその他の症状の治療のためのジヒドロピリジン誘導体 |
| CA2685753A1 (en) | 2007-05-09 | 2008-11-20 | Neuromed Pharmaceuticals Ltd. | Bicyclic pyrimidine derivatives as calcium channel blockers |
| JP6017964B2 (ja) | 2010-03-01 | 2016-11-02 | ティーエーユー・セラピューティクス・エルエルシー | 癌診断および撮像 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59161392A (ja) * | 1983-03-04 | 1984-09-12 | Nippon Shinyaku Co Ltd | ジヒドロピリジン誘導体及びその製法 |
| JPS6069089A (ja) | 1983-09-26 | 1985-04-19 | Nissan Chem Ind Ltd | ジヒドロピリジン−５−ホスホネ−ト誘導体およびその製造法 |
| JPS6163688A (ja) | 1984-08-03 | 1986-04-01 | Nissan Chem Ind Ltd | ジヒドロピリジン−５−ホスホン酸環状エステル類 |
| JPS6130591A (ja) | 1984-07-20 | 1986-02-12 | Nissan Chem Ind Ltd | ジヒドロピリジン−５−ホスホネ−ト誘導体 |
| JPS60248693A (ja) | 1984-04-19 | 1985-12-09 | Nippon Shinyaku Co Ltd | ピリジン誘導体及び製法 |
| JPS60258194A (ja) | 1984-06-01 | 1985-12-20 | Otsuka Pharmaceut Factory Inc | ジヒドロピリジン誘導体 |
| JPS6137793A (ja) | 1984-07-31 | 1986-02-22 | Nissan Chem Ind Ltd | ジヒドロピリジン−２−アミノ−５−ホスホネ−ト誘導体 |
| JPS61210092A (ja) * | 1985-03-14 | 1986-09-18 | Nissan Chem Ind Ltd | ジヒドロピリジン−５−ホスホン酸ジアミド誘導体 |
| MW2586A1 (en) | 1985-04-26 | 1987-12-09 | Hoffmann La Roche | 1,3-disubstituted imidazolium salts |
| JPS61254596A (ja) * | 1985-05-02 | 1986-11-12 | Nissan Chem Ind Ltd | ジヒドロピリジン−５−ホスホン酸エチレンエステル類 |
| US4885284A (en) | 1986-01-22 | 1989-12-05 | Nissan Chemical Industries Ltd. | Dihydropyridine-5-phosphonic acid cyclic propylene ester |
| JPH0655751B2 (ja) | 1986-01-22 | 1994-07-27 | 日産化学工業株式会社 | ジヒドロピリジンホスホン酸環状エステル |
| UA5590A1 (uk) * | 1986-01-23 | 1994-12-28 | Ніссан Кемікал Індастріз Лтд | Спосіб одержання пропіленглікового ефіру заміщеної 1,4-дігідропіріділ-5-фосфорної кислоти, або його фармацевтично прийнятной солі або сольвата |
| JPH0678349B2 (ja) | 1986-01-23 | 1994-10-05 | 日産化学工業株式会社 | ジヒドロピリジン−５−ホスホン酸エステル類 |
| JPH0615553B2 (ja) * | 1986-02-20 | 1994-03-02 | 日産化学工業株式会社 | ジヒドロピリジン−５−ホスホンアミド酸類 |
| JPH0755955B2 (ja) | 1986-09-10 | 1995-06-14 | 日産化学工業株式会社 | 光学活性なジヒドロピリジン−５−ホスホン酸エステル |
| JPH01113398A (ja) | 1987-10-28 | 1989-05-02 | Nissan Chem Ind Ltd | 光学活性なジヒドロピリジン−５−ホスホン酸エステル |
| JPH01275591A (ja) | 1988-04-27 | 1989-11-06 | Nissan Chem Ind Ltd | ジヒドロピリジン−５−ホスホン酸誘導体 |
| JPH0211592A (ja) * | 1988-06-29 | 1990-01-16 | Nissan Chem Ind Ltd | 光学活性なジヒドロピリジンホスホン酸エステル |
| FR2672890A1 (fr) * | 1991-02-20 | 1992-08-21 | Inst Investigacion Desarrol | Derives de 2,6-dimethyl-4-(4'-hydroxy-3',5'-di-t-butylphenyl)-1,4-dihydropyridine, leur procede de preparation et leur utilisation comme capteurs de radicaux libres. |
| SI9200344B (sl) | 1992-11-26 | 1998-06-30 | Lek, | Postopek za pripravo amlodipin benzensulfonata |
| GB9916076D0 (en) * | 1999-07-08 | 1999-09-08 | Smithkline Beecham Plc | Novel compounds |
| DK1200446T3 (da) * | 1999-07-12 | 2005-10-24 | Ortho Mcneil Pharm Inc | Oxathiepino[6,5-b]dihydropyridiner og beslægtede forbindelser og fremgangsmåder |
-
2004
- 2004-03-29 KR KR1020057018357A patent/KR100870527B1/ko not_active IP Right Cessation
- 2004-03-29 TW TW093108552A patent/TW200503733A/zh not_active IP Right Cessation
- 2004-03-29 US US10/549,510 patent/US7563782B2/en not_active Expired - Fee Related
- 2004-03-29 WO PCT/JP2004/004432 patent/WO2004087172A1/ja active Application Filing
- 2004-03-29 JP JP2005504223A patent/JP4539862B2/ja not_active Expired - Fee Related
- 2004-03-29 CA CA2520628A patent/CA2520628C/en not_active Expired - Fee Related
- 2004-03-29 AU AU2004226547A patent/AU2004226547B2/en not_active Ceased
- 2004-03-29 RU RU2005133221/04A patent/RU2326886C2/ru not_active IP Right Cessation
- 2004-03-29 EP EP04724154A patent/EP1609504A4/de not_active Withdrawn
- 2004-03-29 NZ NZ542681A patent/NZ542681A/xx not_active IP Right Cessation
-
2005
- 2005-10-27 NO NO20055015A patent/NO20055015L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2005133221A (ru) | 2006-05-10 |
| EP1609504A1 (de) | 2005-12-28 |
| NZ542681A (en) | 2009-01-31 |
| CA2520628C (en) | 2012-08-14 |
| TW200503733A (en) | 2005-02-01 |
| EP1609504A4 (de) | 2010-07-21 |
| WO2004087172A1 (ja) | 2004-10-14 |
| TWI339581B (de) | 2011-04-01 |
| US7563782B2 (en) | 2009-07-21 |
| RU2326886C2 (ru) | 2008-06-20 |
| KR100870527B1 (ko) | 2008-11-26 |
| JPWO2004087172A1 (ja) | 2006-06-29 |
| KR20050119162A (ko) | 2005-12-20 |
| CA2520628A1 (en) | 2004-10-14 |
| US20070010490A1 (en) | 2007-01-11 |
| AU2004226547B2 (en) | 2008-10-23 |
| NO20055015D0 (no) | 2005-10-27 |
| JP4539862B2 (ja) | 2010-09-08 |
| AU2004226547A1 (en) | 2004-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR025976A1 (es) | Inhibidores de fab i. | |
| DE60317884T8 (de) | Natriumkanalblocker | |
| CO5251397A1 (es) | Inhibidores de fab i | |
| NO20062517L (no) | 2-cyanopyrrolidinkarboksamidforbindelse | |
| NO20033848D0 (no) | Nitrogenholdige heteroarylforbindelser med en HIV integrase inhiberende aktivitet | |
| NO20064077L (no) | Kemokinreseptorantagonister | |
| NO20053246L (no) | Kondensert 1,3-dihydroimidazol-ringforbindelse. | |
| ATE377004T1 (de) | Proteinkinaseinhibitoren | |
| ATE457025T1 (de) | Kinaseinhibitoren | |
| NO20060220L (no) | Forbindelser med inhiberene aktivitet mot natriumavhengige transportorer | |
| NO20082077L (no) | Spirosykliske quinazolinderivater som PDE7-inhibitorer | |
| WO2007016392A3 (en) | Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors | |
| NO20051577L (no) | Azaaren-derivater | |
| AR047339A1 (es) | Derivados de difenilazetidona.proceso de obtencion. | |
| ATE403429T1 (de) | Spiropyrazol-verbindungen | |
| NO331012B1 (no) | N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler | |
| NO20055015L (no) | T-type calcium kanalblokkere | |
| NO20061832L (no) | Karboksamidderivat av amidtype | |
| ATE277011T1 (de) | Flouride von 4-substituierten piperidin-derivaten | |
| NO20063111L (no) | Fremgangsmate for fremstilling av tiazolpyrimidiner | |
| DE60330758D1 (de) | Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen | |
| DK1404642T3 (da) | Fremgangsmåde til fremstillimg af 7-amino-syn-3,5-dihydroxyheptansyrederivater, mellemprodukter derfor og fremgangsmåder til deres fremstilling | |
| ATE526323T1 (de) | Die hiv-protease hemmende verbindungen | |
| NO20071230L (no) | Oksazolidinoner inneholdende oksindoler som antibakterielle midler | |
| EA200500133A1 (ru) | Производные пирролидина в качестве антагонистов окситоцина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |